CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT

The introduction of preoperative concurrent chemoradiotherapy (CCRT) increases the rate of anal preservation and allows tumor downstaging for clinical stage T3/T4 or node-positive rectal cancer patients. However, there is no precise predictive tool to verify the presence of residual tumor apart from...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Chia-Lin, Chen, Tzu-Ju, Tian, Yu-Feng, Chan, Ti-Chun, Yeh, Cheng-Fa, Li, Wan-Shan, Tsai, Hsin-Hwa, Li, Chien-Feng, Lai, Hong-Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304221/
https://www.ncbi.nlm.nih.gov/pubmed/34357018
http://dx.doi.org/10.3390/life11070646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304221/
https://www.ncbi.nlm.nih.gov/pubmed/34357018
http://dx.doi.org/10.3390/life11070646

Ejemplares similares